ATE500275T1 - Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten - Google Patents

Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten

Info

Publication number
ATE500275T1
ATE500275T1 AT06806796T AT06806796T ATE500275T1 AT E500275 T1 ATE500275 T1 AT E500275T1 AT 06806796 T AT06806796 T AT 06806796T AT 06806796 T AT06806796 T AT 06806796T AT E500275 T1 ATE500275 T1 AT E500275T1
Authority
AT
Austria
Prior art keywords
april
antibodies
aprily
patients
lympho
Prior art date
Application number
AT06806796T
Other languages
English (en)
Inventor
Bertrand Huard
Lars French
Olivier Donze
Maximilien Murone
Original Assignee
Enzo Life Sciences Els Ag
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzo Life Sciences Els Ag, Univ Geneve filed Critical Enzo Life Sciences Els Ag
Application granted granted Critical
Publication of ATE500275T1 publication Critical patent/ATE500275T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06806796T 2005-09-26 2006-09-22 Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten ATE500275T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05020881 2005-09-26
PCT/EP2006/066625 WO2007039489A1 (en) 2005-09-26 2006-09-22 Antibodies against april as biomarkers for early prognosis of lymphoma patients

Publications (1)

Publication Number Publication Date
ATE500275T1 true ATE500275T1 (de) 2011-03-15

Family

ID=35636771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06806796T ATE500275T1 (de) 2005-09-26 2006-09-22 Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten

Country Status (9)

Country Link
US (1) US8609821B2 (de)
EP (1) EP1934258B1 (de)
JP (1) JP5227174B2 (de)
AT (1) ATE500275T1 (de)
AU (1) AU2006298794B2 (de)
CA (1) CA2623530C (de)
DE (1) DE602006020467D1 (de)
IL (1) IL190401A0 (de)
WO (1) WO2007039489A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1205764A1 (en) * 2012-04-13 2015-12-24 Somalogic, Inc. Tuberculosis biomarkers and uses thereof
JP2016507066A (ja) * 2013-02-08 2016-03-07 インスティテュート フォー ミエローマ アンド ボーン キャンサー リサーチ 多発性骨髄腫、慢性リンパ球性白血病、およびｂ細胞非ホジキンリンパ腫の改善された診断方法、予後予測方法、およびモニタリング方法
NL2011406C2 (en) * 2013-09-06 2015-03-10 Bionovion Holding B V Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides.
NL2014108B1 (en) 2015-01-09 2016-09-30 Aduro Biotech Holdings Europe B V Altered april binding antibodies.
US10526412B2 (en) * 2015-01-15 2020-01-07 Universite Grenoble Alpes Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the prognosis and/or diagnosis of cancer
KR20250008787A (ko) 2015-11-25 2025-01-15 비스테라, 인크. April에 대한 항체 분자 및 이의 용도
EP4683948A1 (de) 2023-03-21 2026-01-28 Biograph 55, Inc. Multispezifische cd19/cd38-antikörper

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0004611A3 (en) * 1997-09-12 2002-04-29 Apotech R & D Sa April- a novel protein with growth effects
WO2002094192A2 (en) * 2001-05-24 2002-11-28 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (april)

Also Published As

Publication number Publication date
HK1112630A1 (en) 2008-09-12
AU2006298794A1 (en) 2007-04-12
US8609821B2 (en) 2013-12-17
AU2006298794B2 (en) 2012-05-10
EP1934258B1 (de) 2011-03-02
DE602006020467D1 (de) 2011-04-14
EP1934258A1 (de) 2008-06-25
WO2007039489A1 (en) 2007-04-12
JP2009509948A (ja) 2009-03-12
CA2623530C (en) 2015-02-03
JP5227174B2 (ja) 2013-07-03
CA2623530A1 (en) 2007-04-12
US20110143367A1 (en) 2011-06-16
IL190401A0 (en) 2008-11-03

Similar Documents

Publication Publication Date Title
IL190401A0 (en) Antibodies against april as biomarkers for early prognosis of lymphoma patients
RU2007139912A (ru) Способ прогнозирования течения рака на основе количественного анализа клеточного рецептора витамина фолата
AR063125A1 (es) Ensayo elisa para la deteccion de vegf
Puechl et al. Molecular classification to prognosticate response in medically managed endometrial cancers and endometrial intraepithelial neoplasia
EA201190041A1 (ru) Человеческие аутоантитела против альфа-синуклеина
RU2008126743A (ru) Способ получения фармацевтической композиции
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
RU2015104579A (ru) Диагностические анализы и наборы для детекции фолатного рецептора 1
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
DE60228557D1 (de) Candida-nachweis
WO2005108989A3 (en) Assay for antibodies
WO2008012362A3 (en) New protein isoforms and uses thereof
ATE474857T1 (de) Antikörper gegen ein epitop auf agr2, assays und hybridome
SG155931A1 (en) Wnt proteins and detection and treatment of cancer
RU2011144835A (ru) Способы и композиции на основе белков для диагностики колоректальной аденокарциномы
BRPI0815460A2 (pt) kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos
EA200702361A1 (ru) АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ
CN108548923B (zh) 肺小细胞癌早期特异性自身抗体panel诊断试剂盒
CA2643158A1 (en) Methods for diagnosis and prognosis of graft versus host disease by measurement of peripheral cd3+cd4+cd8.beta.+ cells
Trojan et al. Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma.
RU2008111144A (ru) Способы моделирования и ингибирования миграции раковых клеток
WO2003068268A3 (en) Treatment, diagnosis and imaging of disease
AU2002233800A1 (en) Method and kit for predicting cancer
EA200970332A1 (ru) Новые антигены и антитела, ассоциированные с аденокарциномой панкреатического протока
BR0312483A (pt) Anticorpos e seus usos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties